Loss of mitochondrial DNA helicase in retinal macroglia drives neovascular retinopathy.
Saved in:
| Title: | Loss of mitochondrial DNA helicase in retinal macroglia drives neovascular retinopathy. |
|---|---|
| Authors: | Olander S; Stem Cells and Metabolism, Research Programs Unit, Faculty of Medicine, University of Helsinki, Helsinki, Finland., Karaman S; Wihuri Research Institute and Translational Cancer Medicine Program, Faculty of Medicine, University of Helsinki, Helsinki, Finland., Suomi F; Stem Cells and Metabolism, Research Programs Unit, Faculty of Medicine, University of Helsinki, Helsinki, Finland., Aguilar K; Institute of Neurosciences, Universitat Autònoma de Barcelona, Bellaterra, Spain.; Department of Cellular Biology, Physiology and Immunology, Animal Physiology Unit, Faculty of Biosciences, Universitat Autònoma de Barcelona, Bellaterra, Spain., Zhaivoron A; Stem Cells and Metabolism, Research Programs Unit, Faculty of Medicine, University of Helsinki, Helsinki, Finland., Nedergaard M; Center for Translational Neuromedicine, University of Copenhagen, Copenhagen, Denmark.; Department of Neurosurgery, Center for Translational Neuromedicine, University of Rochester Medical Center, Rochester, NY, USA., Smeds L; Molecular and Integrative Biosciences Research Programme, University of Helsinki, Helsinki, Finland., Tiihonen J; Molecular and Integrative Biosciences Research Programme, University of Helsinki, Helsinki, Finland.; Department of Neuroscience and Biomedical Engineering, Aalto University, Espoo, Finland., Quintana A; Institute of Neurosciences, Universitat Autònoma de Barcelona, Bellaterra, Spain.; Department of Cellular Biology, Physiology and Immunology, Animal Physiology Unit, Faculty of Biosciences, Universitat Autònoma de Barcelona, Bellaterra, Spain., Hidalgo J; Institute of Neurosciences, Universitat Autònoma de Barcelona, Bellaterra, Spain.; Department of Cellular Biology, Physiology and Immunology, Animal Physiology Unit, Faculty of Biosciences, Universitat Autònoma de Barcelona, Bellaterra, Spain., Alitalo K; Wihuri Research Institute and Translational Cancer Medicine Program, Faculty of Medicine, University of Helsinki, Helsinki, Finland.; Translational Cancer Medicine Program, Faculty of Medicine, University of Helsinki, Helsinki, Finland., Ala-Laurila P; Molecular and Integrative Biosciences Research Programme, University of Helsinki, Helsinki, Finland.; Department of Neuroscience and Biomedical Engineering, Aalto University, Espoo, Finland., Ince-Dunn G; Stem Cells and Metabolism, Research Programs Unit, Faculty of Medicine, University of Helsinki, Helsinki, Finland. gulayse.ince@gmail.com., Suomalainen A; Stem Cells and Metabolism, Research Programs Unit, Faculty of Medicine, University of Helsinki, Helsinki, Finland. anu.wartiovaara@helsinki.fi.; HUS Diagnostic Center, Helsinki University Hospital, Helsinki, Finland. anu.wartiovaara@helsinki.fi.; HiLife, University of Helsinki, Helsinki, Finland. anu.wartiovaara@helsinki.fi. |
| Source: | EMBO molecular medicine [EMBO Mol Med] 2026 May 08. Date of Electronic Publication: 2026 May 08. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: EMBO Press Country of Publication: Germany NLM ID: 101487380 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1757-4684 (Electronic) Linking ISSN: 17574676 NLM ISO Abbreviation: EMBO Mol Med Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
Be the first to leave a comment!
